Major players in the injectable drug market are Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Schott AG, Baxter International, Owen Mumford, Mylan N.V., and Sanofi.
The global injectable drug delivery devices market is expected to grow from $15.38 billion in 2020 to $17.13 billion in 2021 at a compound annual growth rate (CAGR) of 11.4%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $25.79 billion in 2025 at a CAGR of 10.8%.
The injectable drug delivery devices market consists of sales of conventional syringes, needle-free injectors, auto injectors and pen injectors.The market includes the sales of the Injectable devices that have been extensively utilized for various routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and others to treat medical conditions ranging from cancer to autoimmune disorders.
The injectable drug delivery devices used in hospitals, clinics and home care settings are included in this market.
Emergence of alternative drug delivery devices to injectable drug delivery devices is negatively affecting the market.Injectable (parenteral) drug delivery is one of the widely used conventional drug delivery system.
There are many alternative (painless) drug delivery systems such as nasal, transdermal, transmucosal, vaginal, anal and others which are evolving.The selection of drug delivery system depends on drug release, absorption, distribution, metabolism, and elimination profile of the therapeutic agent in order to achieve highest level of safety and efficacy from the drug.
Alternative drug delivery systems hold key importance in improving bioavailability, reducing toxicity and safety elimination of drug which is administered to treat particular disease.Growing disease related complications, regular developments in drugs and combinations of therapeutic agents are used to treat disease driving the need of alternative drug delivery system.
There are some recent ongoing developments in the field of alternative drug delivery system mainly in nanoparticles-based delivery system, intracellular delivery system, neural delivery system and many more. Thus, emergence of alternative drug delivery methods limits the growth of injectable drug delivery devices market.
The companies in the injectable drug delivery devices are increasingly focusing on the manufacturing of auto injectors.The auto injectors are fully automated, highly customized and reusable injectors that can be used by a patient to perform hundreds of injections.
Patients can control the speed of dose delivery to help minimize pain or discomfort during an injection.These devices have the ability to adjust the speed and depth of the automatic injection.
For instance, LISA, a reusable auto-injector manufactured by Unilife corporation comes with an array of highly customizable features including Bluetooth LE connectivity, Wi-Fi or 3G connectivity and pre-injection drug warming for target therapies. The injectable drug delivery technology market is expected to show significant growth in the coming years, due to various technological advancements and new product launches in order to improve the convenience and ease of administration of parenteral therapeutics.
The increasing preference for self-injection devices is driving the injectable drug delivery devices market.Self-injection devices are medical devices that can be used by the patient in home setting for self-administration of the medication.
Self-Injection devices include needle-free, auto, pen, and wearable injectors.These self-injectables were developed to provide the most adaptable device which has a high precision of drug delivery and is easy to use.
In addition, with the innovations in self-injectable devices, the acceptance of these products has increased over the past few years.BD Physioject is a disposable auto-injector, manufactured by Becton, Dickinson and Company, which is clinically proven, reliable and cost-effective specifically designed for self-injection of drugs by patients suffering from chronic diseases, including rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis.
The other companies currently involved in self-injections market include Abbvie, Inc., 3M, Baxter, Gerresheimer AG, Pfizer Inc and more. The advantages of self-injectable injections and increasing awareness of self-administration have increased the demand for self-injectable devices and will drive the injectable drug delivery devices market during the forecast period.
Our reports have been used by over 10K customers, including:
The global styrenic block copolymer market grew at a CAGR of around 7% during 2015-2020. Styrenic block copolymers (SBCs) which combine the properties of a thermoplastic resin and an elastomer, are a type of block copolymers having an elastomeric central arrangement and polystyrene based end-segments. The central blocks...
Injectable Drug Delivery Technology market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Injectable Drug Delivery Technology Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Injectable Drug Delivery Technology...
Microneedle Drug Delivery Systems market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Microneedle Drug Delivery Systems Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Microneedle Drug Delivery Systems...
United States Connected Drug Delivery Devices Market, By Product Type (Connected Sensors v/s Integrated Connected Devices), By Technology (Bluetooth, Near Field Communication, Others), By Application (Asthma & COPD, Diabetes, Others), By End User (Healthcare Providers v/s Homecare), By Region, Competition Forecast & Opportunities,...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the autoinjectors market are AbbVie, Mylan, Eli Lilly and Company, Amgen, Becton Dickinson and Company, Johnson & Johnson, Teva Pharmaceutical, Merck, Pfizer, Bayer, Biogen, and AstraZeneca. The global autoinjectors market is expected to grow from $2.42 billion in 2020 to $2.94 billion in 2021 at a compound annual growth...
The global chondroitin sulfate market grew at a CAGR of around 4% during 2015-2020. Chondroitin sulfate (CS) is a water-soluble polymer comprising alternating N-Acetylgalactosamine and glucuronic acid, which is naturally found in the cartilage, bone and cornea of animals. CS (C6H13NO5) is anti-atherogenic, inflammatory,...
The global nanomedicine market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 10% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic...
The global transdermal drug delivery systems market exhibited moderate growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of around 6% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.